Psilocybin for treating substance use disorders?

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity

(2016) Rainer Kraehenmann et al.   NeuroImage-Clinical

The role of serotonin in drug use and addiction

(2015) Christian P. Müller et al.   BEHAVIOURAL BRAIN RESEARCH

The dark side of emotion: The addiction perspective

(2015) George F. Koob   EUROPEAN JOURNAL OF PHARMACOLOGY

Restructuring consciousness –the psychedelic state in light of integrated information theory

(2015) Andrew R. Gallimore   Frontiers in Human Neuroscience

Cortisol awakening response predicts intrinsic functional connectivity of the medial prefrontal cortex in the afternoon of the same day

(2015) Jianhui Wu et al.   NEUROIMAGE

Increased Serotonin Transporter Expression Reduces Fear and Recruitment of Parvalbumin Interneurons of the Amygdala

(2015) Marco Bocchio et al.   NEUROPSYCHOPHARMACOLOGY

5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking

(2015) In-Jee You et al.   NEUROPSYCHOPHARMACOLOGY

The role of serotonin 5-HT2A receptors in memory and cognition

(2015) Gongliang Zhang et al.   Frontiers in Pharmacology

Reduced cocaine-induced serotonin, but not dopamine and noradrenaline, release in rats with a genetic deletion of serotonin transporters

(2014) Michel M.M. Verheij et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

(2014) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

How the amygdala affects emotional memory by altering brain network properties

(2014) Erno J. Hermans et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Early life adversity and serotonin transporter gene variation interact at the level of the adrenal gland to affect the adult hypothalamo-pituitary-adrenal axis

(2014) R H A van der Doelen et al.   Translational Psychiatry

Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex

(2014) Cristiano Bombardi   Frontiers in Pharmacology

Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety

(2013) Esther Asan et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010

(2013) Louisa Degenhardt et al.   LANCET

Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats

(2013) Jade M. Franklin et al.   NEUROSCIENCE LETTERS

Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol

(2013) Katarzyna Stebelska   THERAPEUTIC DRUG MONITORING

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment

(2013) Brittany Vasae Burdick et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

(2012) Michael Kometer et al.   BIOLOGICAL PSYCHIATRY

A fatal case of ‘magic mushroom’ ingestion in a heart transplant recipient

(2012) T. H. Lim et al.   INTERNAL MEDICINE JOURNAL

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Resting state functional connectivity in addiction: Lessons learned and a road ahead

(2012) Matthew T. Sutherland et al.   NEUROIMAGE

Prediction of Psilocybin Response in Healthy Volunteers

(2012) Erich Studerus et al.   PLoS One

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Limbic-Hypothalamic-Pituitary-Adrenal Axis and the Development of Alcohol Use Disorders in Youth

(2011) Ty S. Schepis et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

The interplay between brain 5-hydroxytryptamine levels and cocaine addiction

(2011) Lourens J.P. Nonkes et al.   BEHAVIOURAL PHARMACOLOGY

Blunted Cortisol Responses to Stress Signal Social and Behavioral Problems Among Maltreated/Bullied 12-Year-Old Children

(2011) Isabelle Ouellet-Morin et al.   BIOLOGICAL PSYCHIATRY

Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats

(2011) Toshimichi Hata et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats

(2011) Ashley Furr et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

(2011) Adam L. Halberstadt et al.   NEUROPHARMACOLOGY

Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research

(2011) Cinnamon Stetler et al.   PSYCHOSOMATIC MEDICINE

Large-scale brain networks and psychopathology: a unifying triple network model

(2011) Vinod Menon   TRENDS IN COGNITIVE SCIENCES

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

(2010) Ronan Depoortère et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Forensic analysis of hallucinogenic mushrooms and khat (Catha edulisForsk) using cation-exchange liquid chromatography

(2010) Tim Laussmann et al.   FORENSIC SCIENCE INTERNATIONAL

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Brain stress systems in the amygdala and addiction

(2009) George F. Koob   BRAIN RESEARCH

Neurocircuitry of Addiction

(2009) George F Koob et al.   NEUROPSYCHOPHARMACOLOGY

The role of 5-HT1A receptors in learning and memory

(2008) Sven Ove Ögren et al.   BEHAVIOURAL BRAIN RESEARCH

Five-Factor Model personality profiles of drug users

(2008) Antonio Terracciano et al.   BMC Psychiatry

5-HT2A receptor mediated neuronal activation within the paraventricular nucleus of the hypothalamus is desensitized following prolonged glucocorticoid treatment

(2008) Tiffany T.-Y. Lee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neural predictors of moment-to-moment fluctuations in cognitive flexibility

(2008) A. B. Leber et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats

(2008) Judith R. Homberg et al.   PSYCHOPHARMACOLOGY

Serotoninergic regulation of emotional and behavioural control processes

(2007) Roshan Cools et al.   TRENDS IN COGNITIVE SCIENCES